Final Medicare Part D Rule
The following statement is from NHC’s Chief Executive Officer, Marc Boutin, JD:
Today, CMS rolled back proposed changes to the Medicare Part D six protected classes. This is a great win for the patient community. We thank CMS for listening to the concerns of patients and for not restricting access to needed medications. We are also pleased CMS finalized changes to increase drug pricing transparency for patients and providers. We look forward to advancing our work with Congress and the Administration to reduce drug costs for our nation’s seniors.